197 related articles for article (PubMed ID: 5759685)
1. [A new anticoagulant: ethyldicoumarol 75].
Warembourg H; Ducloux G
Lille Med; 1968 Mar; 13(3):Suppl:257-9. PubMed ID: 5759685
[No Abstract] [Full Text] [Related]
2. [Practical use of anti-prothrombin treatments].
Chiche P; Berkman M; Savier CH
Sem Ther; 1967 Oct; 43(8):448-9. PubMed ID: 5623992
[No Abstract] [Full Text] [Related]
3. Clinical impressions of a new beta-adrenergic blocking drug, 39,089-Ba.
Wilson DF; Turner AS
N Z Med J; 1967 Oct; 66(422):682-3. PubMed ID: 4864443
[No Abstract] [Full Text] [Related]
4. [Cardio-energetic heart therapy].
Beyreder J
Wien Med Wochenschr; 1968 Sep; 118(37):717-21. PubMed ID: 5726708
[No Abstract] [Full Text] [Related]
5. [Verapamil in ischemic pain and arrhythmia].
Waris E
Duodecim; 1972; 88(20):1223-32. PubMed ID: 5076303
[No Abstract] [Full Text] [Related]
6. [Experience with the use of sodium hydroxybutyrate in patients with acute coronary insufficiency and cardiac rhythm disorders].
Popov VG; Kharkevich DA; Syrkin AL; Basistov AF; Lazebnik LB; Lazutin VK
Ter Arkh; 1968 Dec; 40(12):44-7. PubMed ID: 5746542
[No Abstract] [Full Text] [Related]
7. [Myocardial infarct as a stochastic manifestation].
Drdková S; Zaloudek M
Cesk Zdrav; 1969; 17(10):437-9. PubMed ID: 5343835
[No Abstract] [Full Text] [Related]
8. [Effect of heparin and pelentan on the biopolymer metabolism of connective tissue in myocardial infarct].
Sharaev PN; Leshchinskiĭ LA; Pimenov LT; Vtorov AE
Farmakol Toksikol; 1984; 47(1):44-6. PubMed ID: 6705903
[TBL] [Abstract][Full Text] [Related]
9. [Therapy of the functionally disturbed heart with regard to its vascular and nervous supply].
Leonard W
Hippokrates; 1968 Jan; 39(2):69-72. PubMed ID: 5716576
[No Abstract] [Full Text] [Related]
10. [The use of inderal in angina pectoris and arrhythmias].
Krasnikov IuA
Ter Arkh; 1967 Jul; 39(7):84-7. PubMed ID: 5610938
[No Abstract] [Full Text] [Related]
11. [The beta-blockers in coronary disease].
Broustet JP; Sermon F; Rumeau P; Pic A
Rev Prat; 1984 Apr; 34(19):953-64. PubMed ID: 6144162
[No Abstract] [Full Text] [Related]
12. [Therapeutic possibilities in coronary disease].
Zoli I; Baroncini S; Cornia GL; Donato S; Minore G; Pigini G; Pretolani E
Minerva Med; 1973 Nov; 64(84):4445-57. PubMed ID: 4272415
[No Abstract] [Full Text] [Related]
13. [Clinical experiments with a new myocardiotrophic agent].
Amadini S; Bagnoli L
Clin Ter; 1970 Sep; 54(5):441-53. PubMed ID: 4949932
[No Abstract] [Full Text] [Related]
14. [Beta-adrenergic inhibitors and coronary insufficiency].
Juliard JM; Dahan M; Cohen Solal A; Gourgon R
Therapie; 1985; 40(6):393-6. PubMed ID: 2868533
[No Abstract] [Full Text] [Related]
15. [Therapeutic use of beta-receptor blocking agents].
Wallnöfer H; Bereitter E
Wien Klin Wochenschr; 1968 Apr; 80(15):288-92. PubMed ID: 5688615
[No Abstract] [Full Text] [Related]
16. [The treatment of cardio-coronary diseases with gradulon].
Trieb G
Munch Med Wochenschr; 1971 Oct; 113(42):1384-90. PubMed ID: 4107490
[No Abstract] [Full Text] [Related]
17. Contribution to the evaluation of long-term anticoagulant treatment in patients after myocardial infarction.
Cihàk J
Rev Czech Med; 1977; 23(3):150-7. PubMed ID: 410082
[No Abstract] [Full Text] [Related]
18. Clinical pharmacology of calcium antagonists.
Millar JA; Bramley PM
Methods Find Exp Clin Pharmacol; 1984 Apr; 6(4):205-11. PubMed ID: 6379348
[No Abstract] [Full Text] [Related]
19. [Effect of anticoagulant therapy on vascular permeability in patients with ischemic heart disease].
Guliamov KhG
Ter Arkh; 1974; 46(9):75-80. PubMed ID: 4439311
[No Abstract] [Full Text] [Related]
20. Adverse reactions associated with heparin therapy for ischemic heart disease and thrombophlebitis.
Mishler JM
Am J Hosp Pharm; 1973 Dec; 30(12):1158-61. PubMed ID: 4763223
[No Abstract] [Full Text] [Related]
[Next] [New Search]
